Insider Trading24 Jun 2026, 12:39 pm
Aspira Pathlab Closes Trading Window for Q1 FY27 Results
AI Summary
Aspira Pathlab & Diagnostics Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is effective from July 1, 2026, and will continue until the declaration of the unaudited standalone financial results for the quarter ended June 30, 2026, plus 48 hours thereafter. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, aimed at preventing insider trading during the sensitive period of financial reporting.
Key Highlights
- Trading window closed from July 1, 2026.
- Closure is for Q1 FY27 financial results announcement.
- Applies to designated persons and immediate relatives.
- Aims to prevent insider trading as per SEBI regulations.
Price Impact
More from ASPIRA